Posts Tagged ‘clinical research’

The V Foundation for Cancer Research has invited OHSU to submit applications for two of their research programs this cycle: The V Foundation Translational Myelodysplastic Syndromes Research Project Offers up to $400,000 over two years in support of a translational research project on Myelodysplastic Syndromes as it relates to people with or at risk for cancer. Deadlines Internal deadline: May 17, 2013 Letter of Intent: May 31, 2013 Full application (by invitation only): June 19, … Read More

The Human Investigations Program (HIP) trains scientists in the principles of and best practices in clinical and translational research. It offers an integrated clinical and translational education curriculum. Participants can obtain a Certificate in Human Investigations or a Master of Clinical Research degree – and a non-degree track allows enrollment in individual courses. The curriculum includes a wide variety of requirements and electives that will provide a rich background in human investigation – everything from the … Read More

This July 28-31, 2013, OHSU will host the 2013 Oregon Institute for Patient-Centered Comparative Effectiveness (ICE) Annual Research Intensive. National leaders in the fields of patient-centered outcomes and comparative effectiveness research (PCOR & CER) will be coming to OHSU to teach this intensive, hands-on workshop. The program is a week-long activity sponsored by the National Institutes of Health and the National Cancer Institute. The fields of PCOR & CER are rapidly evolving with new opportunities for … Read More

Did you know that OHSU has pre-made templates for clinical study recruitment flyers and advertisements? The OHSU Branding Committee asks that you please use these templates when creating posters or advertisements for clinical studies to ensure a consistent look and feel. Visit the OHSU Branding site and scroll down to “Research Templates.”

The V Foundation for Cancer Research – Translational Awards provide up to $200,000 per year for three years to fund projects that intend to develop novel, translational approaches to the prevention, detection and treatment of human cancer. Collaboration of investigators from both the lab and clinic is required. Project teams must have a minimum of two scientists from the same facility and the team must possess basic and clinical research expertise. One application is permitted … Read More

The Oregon Clinical & Translational Research Institute (OCTRI) has just funded four research awards in the second round of its Catalyst Pilot Projects Program. The program is designed to launch multidisciplinary studies to further translational research and the awards support the collection of data essential to launch compelling applications for sustained national research funding. The funding was available through support from the NIH, the School of Medicine and the Office of the Vice President of … Read More

Continuing review is the ongoing monitoring mechanism by which Institutional Review Boards (IRBs) ensure the continuing protection of subjects who participate in research. The questions below, which are part of the Continuing Review Questionnaire, can be a confusing. Here are some helpful hints to determine who really is considered enrolled in your study. Question 5.5  Total subjects since study began In studies dealing with a warm body, this number includes all subjects who signed a consent … Read More

Join us for January’s HIP Buffet seminar for a look at Recruitment and Study Feasibility Resources for clinical researchers. The seminar will be held Wednesday, January 23 from 12 to 1 p.m. in Mackenzie Hall, room 1116 and presented by Darlene Kitterman, MBA, Program Director, Oregon Clinical and Translational Research Institute (OCTRI) Investigator Support & Integration Services.  Recent research shows that nearly one third of clinical studies are terminated due to low enrollment. You can … Read More

The Office for Civil Rights (OCR) released new guidance on November 26, 2012, that elaborates on HIPAA’s data de-identification standards. Under the HIPAA Privacy Rule, there are two ways that health information can be de-identified and therefore no longer considered Protected Health Information (PHI): Remove all 18 listed identifiers (the “safe harbor” method); or Obtain confirmation from a qualified statistician that the risk of identification is very small (the “expert determination” method). Most researchers are … Read More

Four times a year, the Medical Research Foundation of Oregon offers grants for promising biomedical exploration and the development of research careers in clinical investigation. The next deadline for these awards is February 15, 2013. Please note that all application guidelines have been changed as of January 1, 2013. Review all guidelines carefully before submitting your application. The New Investigator Grant supports junior faculty who are new to research and are currently without major funding … Read More